Conference abstractPublished 10 Sep 2012
Myelo proliferative disorder (myeloid leukemia) vis-a-vis triyak raktapitta and its ayurvedic management – a clinico –theoretical review
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Myeloid leukemia (ML) is very commonly myelo proliferative disorder. The important pathophysiological change observed is the increased cellularity esp. of myeloid series. Thus it is resulting in the increase of the viscosity of blood i.e. lohitabhisyanda. This is the characteristic change observed in raktapitta. Thus it is kept at equality. Triyak raktapitta is advanced phase of the raktapitta where the blood oozes out even from the romakupa. This is tridoshaja condition and bears poor prognosis, because of non-effectiveness of therapeutic purification processes or limited availability of tridosha shamak drugs. It is observed that on the basis of the clinical experience that the chronic myeloid leukemia (CML) is managed effectively with providing good symptom relief and improving general wellbeing. The average life span of the patient is believed to be five to ten years, but it is observed that the life span of the patients managed with ayurvedic live even more than fifteen years. Tools for evaluation for the life expectancy are yet not very much perfect, so calming the improvement of life expectancy is not justified, but it is certain that the wellbeing of the patients improves with symptom relief.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Nishant Shukla”
